Kinnate Biopharma Inc

Jennerex Biotherapeutics Inc, based in San Francisco, CA, is a global leader in oncolytic immunotherapeutics, specializing in targeting, attacking, and eradicating cancers. Their most advanced product candidate, Pexa Vec, is engineered to selectively infect and replicate in cancer cells by leveraging genetic changes common in cancer cells. In addition to Pexa Vec, Jennerex Biotherapeutics is actively developing their next-generation pipeline, JX 970, which has shown promising tumor debulking effects and a selective preference for tumor tissues in preclinical studies. The company is dedicated to advancing innovative treatments for cancer through strategic partnerships and ongoing research efforts. Generated from the website

Phil Pharmacy Solutions LLC, based in San Francisco, CA, is dedicated to ensuring the protection and privacy of patients' health information in accordance with HIPAA regulations. The company offers a range of services including medication management, treatment coordination, and health care operations to enhance the quality of care while maintaining confidentiality. Emphasizing transparency, Phil Pharmacy Solutions LLC provides patients with a comprehensive Notice of Privacy Practices, outlining their rights regarding personal health information. Additionally, the organization is committed to notifying individuals in the event of a data breach and supports compliance with health oversight activities. Generated from the website

Founded in 1980, Celgene Corporation is a full-service, multinational biopharmaceutical company. It has been approved by the Food Drug and Administration to market the THALOMID brand products used in the treatment of erythema nodosum leprosum. The company offers products from the VIDAZA, REVLIMID and ALKERAN brands. Celgene Corporation provides placental and cord blood banking services through LifebankUSA. The company conducts investigation compound studies on patients with hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndrome, chronic lymphocyte leukemia and glioblastoma. It also offers research and development, patient support and medical services for individuals. Celgene Corporation has a staff of more than 1,500 employees.